INTRODUCTION
============

Most patients with head and neck cancer successfully receive oncologic resection followed by free or local flap reconstruction, depending on the tumor's size and location \[[@b1-aps-2019-00157],[@b2-aps-2019-00157]\]. Locoregional flaps, such as pectoralis major muscle island flaps or temporalis muscle flap transpositions, are widely used. In addition to local flaps, microvascular free flap surgery---with options including anterolateral thigh free flaps, radial forearm free flaps, and vertical rectus abdominis myocutaneous free flaps---is also employed because this technique can yield both cosmetic and functional reconstruction in one step \[[@b3-aps-2019-00157]\]. With a flap failure rate of less than 5% at most institutions, surgical resection of the tumor followed by reconstruction can be performed without an undue burden \[[@b4-aps-2019-00157]\]. Despite effective curative resection and reconstruction, head and neck cancer patients face a high risk of recurrence \[[@b5-aps-2019-00157],[@b6-aps-2019-00157]\]. In addition, patients with a history of head and neck cancer are at risk of a second primary cancer at a rate of 5%--30% \[[@b7-aps-2019-00157]\]. In these cases, surgeons inevitably choose additional treatments including operations. In these patients, the optimal treatment choice is considered to be sequential curative resection and reconstruction, just as in those with primary cancer \[[@b5-aps-2019-00157]\]. Sequential reconstruction is defined as reconstruction following the resection of a recurrent tumor even though a previous reconstructive procedure was performed at the same site. However, due to a lack of recipient vessels, altered anatomy, risk of flap loss, and other complications, reasonable hesitation to perform sequential reconstructions often occurs before an additional operation \[[@b4-aps-2019-00157],[@b8-aps-2019-00157],[@b9-aps-2019-00157]\]. Although these factors might negatively affect a secondary operation, few large-scale studies have investigated the operative outcomes of sequential reconstruction following recurrent head and neck cancer. Therefore, we conducted a retrospective review of sequential reconstructions performed during a 10-year period at our institution. We sought to determine whether additional microvascular or locoregional reconstruction was the optimal treatment strategy. In this study, we evaluated the outcomes of sequential reconstructions for patients who experienced recurrent head and neck cancer and postoperative complications associated with reoperation.

METHODS
=======

A review of patients who experienced recurrent head and neck cancer followed by reconstruction with a locoregional flap or a free vascularized flap at our center between 2008 and 2017 was performed. Patients were included in our sample if they underwent reconstruction following curative resection of recurrent head and neck cancer, regardless of the reconstruction method used during the first procedure. Additional reconstructions due to nonmalignant lesions were not included in our sample. Thus, only patients who underwent sequential curative resection of recurrent head and neck cancer followed by reconstruction were included in this study.

Our review included 58 total patients who received sequential head and neck reconstructions. A retrospective review of their demographic characteristics and outcomes was carried out. We analyzed the cancer sites, amount of time until recurrence, pathology, the initial and recurrent cancer stages, and any chemotherapy and radiotherapy that took place. The final reconstruction strategies were categorized as either a free flap or a local flap. In cases where a free vascularized flap was performed, micro-anastomosed arteries and veins were reconstituted. We also analyzed any postoperative complications. Continuous data are represented as mean±standard deviation.

RESULTS
=======

A total of 457 patients underwent head and neck reconstruction following tumor resection. Among them, 58 patients underwent reconstruction following curative resection of recurrent head and neck cancer, including 43 males (74.1%) and 15 females (25.9%). The average follow-up period was 44.2±39.4 months, with a range from 3 months to 143 months. Twenty-nine patients (50%) died during follow-up due to old age, other medical conditions, and tumor recurrence. The 1-year survival rate was 74.1% and the 5-year survival rate was 50%. The number of patients who died after being diagnosed with a local recurrent tumor or distant metastasis was 15 (25.9%). Fourteen patients (24.1%) died for other reasons, including old age, heart, lung disease, and intracranial hemorrhage. There were no cases of failed reconstruction following curative resection of recurrent head and neck cancer at our institution. Patients' demographic characteristics, including tumor location, pathology, and stage, are listed in [Table 1](#t1-aps-2019-00157){ref-type="table"}. The mean age of patients at the time of the initial operation was 55.4±15.3 years, and the average age at the most recent procedure was 59.0±14.3 years. The mean interval between operations was 49.2±62.4 months. Twelve patients (20.7%) underwent surgery on the tongue, 12 patients (20.7%) on the oropharynx, nine patients (15.5%) on the oral cavity, and seven patients (12.1%) on the maxilla. The most common type of malignancy was squamous cell carcinoma, which was found in 43 patients (74.1%), followed by adenocarcinoma in eight patients (13.8%). At the time of the first operation, 19 patients (32.8%) had stage I malignancy, while 15 (25.9%) were diagnosed with stage IV malignancy. Upon recurrence, the largest number of patients had stage IV malignancy (24 patients; 41.4%), followed by stage I malignancy (15 patients; 25.9%). Twelve patients (22.4%) underwent chemotherapy, while 29 (50.0%) received radiotherapy. Twelve patients (20.7%) experienced recurrence after sequential reconstruction, of whom two patients (3.4%) underwent local excision and nine patients (15.5%) died. Eight patients (13.8%) were diagnosed with distant metastasis, with metastatic sites including the bone, lung, brain and neck, of whom six patients (10.3%) died. Twenty patients (34.5%) underwent postoperative radiotherapy and 18 patients (31.0%) underwent postoperative chemotherapy after sequential reconstruction.

The different types of flaps are listed in [Table 2](#t2-aps-2019-00157){ref-type="table"}. Eleven patients (19.0%) received two free flap procedures, and 10 patients (17.2%) underwent three or more total operations. Thirty-four patients (58.6%) were treated using a sequential free flap reconstruction, while 24 patients (41.4%) received local flaps. An anterolateral thigh free flap was used for 11 patients (19.0%), followed by a radial forearm free flap in 10 patients (17.2%) and a rectus abdominis free flap in six patients (10.3%). A pectoralis major flap was used for 14 patients (24.1%), while five (8.6%) were treated with a temporalis muscle flap.

In patients who received a free flap, the superficial thyroid artery was most commonly chosen for arterial micro-anastomosis (26 patients; 76.5%), and a branch of the internal jugular vein was the most common site for micro-anastomosis of a vein (19 patients; 55.9%) ([Table 3](#t3-aps-2019-00157){ref-type="table"}). The facial artery, lingual artery, transverse cervical artery and superior thyroid vein, external jugular vein, facial vein, and transverse cervical vein were also used for micro-anastomoses. All anastomoses but one were conducted in an end-to-end fashion; in one case, the vein was anastomosed in an end-to-end fashion with a radial forearm free flap.

In total, 13 complications occurred. In two patients (3.45%), re-exploration was performed within 1 week of the reconstruction; in another two patients (3.45%), re-exploration took place after 1 week. Although partial flap loss was noted in two patients (3.45%), there were no total losses of any flaps. There was also one case of hematoma (1.72%) and four cases that required minor revisions (6.90%) ([Table 4](#t4-aps-2019-00157){ref-type="table"}).

Patients' swallowing and speech abilities were evaluated at an outpatient clinic. Seventeen patients (29.3%) who underwent reconstruction of the extra-oropharynx region, such as the cheek, ear, and forehead, had undisrupted swallowing and speech and were not examined. In addition, eight patients (13.8%) died before the examination. Of the rest of the patients, 12 (20.7%) were able to ingest solid meals, 14 (24.1%) ate only soft meals, and seven (12.1%) could not eat anything. With regard to speech, eight patients (13.8%) had normal speech, 11 (19.0%) had an impediment, and 14 (24.1%) were unable to speak.

DISCUSSION
==========

This study presents a thorough investigation of reconstruction procedures for recurrent head and neck cancer involving 58 patients during a period of 10 years. At our institution, 26 patients required subsequent repetitive reconstructive surgery. Eleven patients received a subsequent free vascularized flap, while 10 patients underwent three or more reconstructive operations. These subsequent reconstructive procedures were more challenging than the initial operation due to scarring from the first operation, fibrosis caused by radiation, and other structural changes that hindered the surgeon in cases with difficult anatomy \[[@b10-aps-2019-00157]\]. Nonetheless, no patient experienced total flap loss. Our experience suggests that sequential reconstructive surgery is worth considering for recurrent head and neck cancer patients, even if they have undergone prior reconstructions, such as local and free vascularized flaps. These findings should aid oncologists in the selection of treatment strategies, including wide surgical removal, when patients experience tumor recurrence.

In our study, 24 patients (41.4%) underwent reconstruction using a locoregional flap. A pectoralis major flap was mostly preferred (14 cases; 24.1%). Some studies have suggested that in appropriate surgical locations and in cases with contraindications for microvascular surgery, a pectoralis major flap should still be considered for head and neck reconstruction despite the current trend toward microvascular reconstruction \[[@b11-aps-2019-00157]-[@b13-aps-2019-00157]\]. Other types of locoregional flaps have also been used, such as a temporalis muscle flap or a palatal flap. However, considering the location and size of the defect following a wide tumor resection, a pectoralis major flap was the most adequate locoregional flap. In another study, the authors suggested that a trapezius island myocutaneous flap was also a suitable option for head and neck reconstruction \[[@b14-aps-2019-00157]\]. However, our surgeons did not use this technique; moreover, most of them preferred free flaps, such as an anterolateral thigh free flap, which was used in 11 cases (20.0%), followed by a radial forearm free flap in 10 cases (17.2%). In general, the length or diameter of the pedicle of an anterolateral thigh flap and a radial forearm flap are known to be adequate for head and neck reconstructions \[[@b10-aps-2019-00157],[@b15-aps-2019-00157]-[@b17-aps-2019-00157]\]. In this study, the choice of flap to use in a patient with recurrent cancer was the same as that in a primary cancer case.

Out of 34 free flap cases, the superficial temporal artery was used in 26 cases (76.47%), and a branch of the internal jugular vein was employed in 19 cases (55.88%) for micro-anastomoses. Even in patients who underwent repeated reconstruction, no flap loss was noted. In some studies, repeated free flap procedures were successfully performed by re-using the same vessels as the prior operation, and no flap failures occurred \[[@b10-aps-2019-00157],[@b18-aps-2019-00157]\]. According to our study, the use of familiar vessels yields positive outcomes, even when structural changes are present due to prior radiation or reconstruction.

In a previous study, several episodes of microvascular reconstruction were associated with postoperative complications, such as a longer hospital stay, total flap failure, fistula, infection, and anastomosis thrombosis \[[@b19-aps-2019-00157]\]. In the current study, postoperative complications were noted in 13 cases (22.4%). Total re-explorations were performed in four cases (6.90%). Of these cases, two (3.45%) occurred within 1 week, which may suggest thrombosis or technical factors such as the micro-anastomosis technique used. However, no flap became detached. In every case, appropriate patient-oriented judgment was required to determine the best treatment. The seven patients with impaired swallowing ability and 14 patients with impaired speech ability presented similar results to those of the prior assessment after primary reconstruction.

Our study had several limitations. First, the study was a retrospective review performed at a single institution that was entirely dependent on medical records. Second, since some cases were so recent, the overall long-term survival rate was not available. Patients who experience recurrent head and neck cancer are considered to have a poor prognosis, so further investigations should be carried out in the future. Third, although the surgeons at our institution are sufficiently qualified to perform several reconstructive operations, their choice of flaps was limited. We did not use relatively unfamiliar flaps, such as trapezius island myocutaneous flaps or superficial circumflex iliac artery perforator free flaps.

The oncologic prognosis for recurrent head and neck cancer has gradually improved, and patients are expected to live longer than before \[[@b20-aps-2019-00157]\]. As the long-term survival rate increases in these patients, it will be necessary to strongly recommend performing reconstructive surgery to obtain satisfactory results compared to those produced by conservative care \[[@b21-aps-2019-00157]-[@b23-aps-2019-00157]\].

No potential conflict of interest relevant to this article was reported.

**Ethical approval**

The study was approved by the Institutional Review Board of Severance Hospital (IRB No. 4-2019-0365) and performed in accordance with the principles of the Declaration of Helsinki.

**Author contribution**

Conceptualization: Lee WJ. Date curation: Lee WJ. Formal analysis: Chung SW, Byun IH. Methodology: Chung SW, Byun IH, Lee WJ. Project administration: Chung SW, Byun IH, Lee WJ. Visualization: Chung SW, Byun IH. Writing - orginal draft: Chung SW. Writing - review & editing : Chung SW. Approval of final manuscript: all authors.

###### 

Patient characteristics

  Characteristics                    Value
  ---------------------------------- ---------------
  No. of patients                    58
  Sex                                
   Male                              43 (74.13)
   Female                            15 (25.86)
  Age at initial operation (yr)      55.40 ± 15.27
  Age at sequential operation (yr)   59.04 ± 14.29
  Term between operations (mon)      49.2 ± 62.4
  Follow-up period (mon)             44.2 ± 39.4
  Reconstruction sites               
   Tongue                            12 (20.69)
   Oropharynx                        12 (20.69)
   Oral cavity                       9 (15.52)
   Maxilla                           7 (12.07)
   Hypopharynx                       5 (8.62)
   Parotid gland                     5 (8.62)
   External auditory canal           3 (5.17)
   Skin                              2 (3.45)
   Lacrimal gland                    2 (3.45)
   Mandible                          1 (1.72)
  Pathology                          
   Squamous cell carcinoma           43 (74.13)
   Adenocarcinoma                    8 (13.79)
   Mucoepidermoid carcinoma          2 (3.45)
   Pleomorphic carcinoma             2 (3.45)
   Malignant melanoma                1 (1.72)
   Basal cell carcinoma              1 (1.72)
   Myoepithelial carcinoma           1 (1.72)
  Initial stage                      
   I                                 19 (32.76)
   II                                11 (18.97)
   III                               13 (22.41)
   IV                                15 (25.86)
  Recurrent stage                    
   I                                 15 (25.86)
   II                                6 (10.34)
   III                               13 (22.41)
   IV                                24 (41.38)
  Chemotherapy                       12 (20.69)
  Radiotherapy                       29 (50.00)
  ≥ 2 Free flaps                     11 (18.97)
  ≥ 3 Operations                     10 (17.24)

Values are presented as number (%) or mean±SD.

###### 

Types of flaps used

  Flap                   No. (%)
  ---------------------- ------------
  Free flap              34 (58.62)
   Anterolateral thigh   11 (18.97)
   Radial forearm        10 (17.24)
   Rectus abdominis      6 (10.34)
   Vastus lateralis      3 (5.17)
   Latissimus dorsi      2 (3.45)
   Fibula                2 (3.45)
  Local flap             24 (41.38)
   Pectoralis major      14 (24.14)
   Temporalis            5 (8.62)
   Tongue                2 (3.45)
   Palate                2 (3.45)
   Latissimus dorsi      1 (1.72)

###### 

Micro-anastomosis recipient vessels (n=34)

  Vessel                 No. (%)
  ---------------------- ------------
  Artery                 
   Superior thyroid      26 (76.47)
   Facial                4 (11.76)
   Lingual               3 (8.82)
   Transverse cervical   1 (2.94)
  Vein                   
   Branch of IJV         19 (55.88)
   Superior thyroid      6 (17.65)
   EJV                   4 (11.76)
   Facial                4 (11.76)
   Transverse cervical   1 (2.94)

IJV, internal jugular vein; EJV, external jugular vein.

###### 

Postoperative complications

  Complications                  No. (%)
  ------------------------------ ----------
  Re-exploration within 1 week   2 (3.45)
  Total re-exploration           4 (6.90)
  Partial flap loss              2 (3.45)
  Hematoma                       1 (1.72)
  Minor revision                 4 (6.90)
